RedHill Biopharma Ltd.
RDHL
$1.64
-$0.09-5.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 69.14% | 68.46% | -- | -- | -- |
| Total Depreciation and Amortization | -55.16% | 100.85% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.48% | -101.78% | -- | -- | -- |
| Change in Net Operating Assets | 91.37% | 104.56% | -- | -- | -- |
| Cash from Operations | 66.16% | 72.31% | -- | -- | -- |
| Capital Expenditure | -140.00% | 8.70% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -220.00% | -400.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 58.90% | 51.80% | -- | -- | -- |
| Issuance of Common Stock | -79.87% | -54.94% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -91.20% | -92.57% | -- | -- | -- |
| Cash from Financing | -84.60% | -70.38% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 196.00% | 512.50% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,669.75% | 75.95% | -- | -- | -- |